EUVIMEDEUVIMED entdecken
Vergleichsstudie

Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation

Yakub Patat, Gülşah Akyol, Muzaffer Keklik, Ali Ünal, Leylagül Kaynar

Transplantation Proceedings · 2026-05 · 58 (4) · 816-821

DOI: 10.1016/j.transproceed.2026.03.015 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Transplantation Proceedings, 2026-05. Verfasst von Yakub Patat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Erciyes University, Kayseri, Türkiye. Hauptthemen laut MEDLINE: Levofloxacin, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Rifaximin. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to compare the effects of rifaximin and levofloxacin prophylaxis in allogeneic hematopoietic stem cell transplantation (HSCT) on the development of graft-versus-host disease (GVHD), length of hospital stay, engraftment duration, initiation of broad-spectrum antibiotics, incidence of febrile neutropenia, relapse rates, readmission periods, and transplant-related mortality. A total of 116 patients aged over 18 who underwent allogeneic HSCT between 2018 and 2022 were included. Exclusion criteria included the use of broad-spectrum antibiotics on the day of transplantation. Of these, 58 patients received rifaximin, and 58 received levofloxacin as prophylaxis. Levofloxacin was associated with a significantly lower incidence of febrile neutropenia in patients with acute myeloid leukemia (AML) compared to rifaximin (P = .017). Among other patient groups, levofloxacin prophylaxis also resulted in a lower fever incidence (P = .031). Levofloxacin demonstrated greater efficacy than rifaximin in reducing the incidence of transition to broad-spectrum antibiotic therapy (P = .008). Among the 116 patients, 54 were readmitted within the first 100 days post-transplantation. Among these, the predominant reason for readmission was infection, followed by graft-versus-host disease (GVHD). The use of levofloxacin prophylaxis was linked to a remarkably lower rate of readmissions (P = .004). In patients with acute lymphoblastic leukemia (ALL), levofloxacin also showed a significant advantage in terms of readmission rates. Moreover, individuals who received levofloxacin for prophylaxis experienced reduced mortality rates (P = .011).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinHematopoietic Stem Cell TransplantationGraft vs Host DiseaseRifaximinAnti-Bacterial AgentsHumansFemaleTransplantation, HomologousMaleAdultMiddle AgedFebrile NeutropeniaRetrospective StudiesLength of Stay

Substanzen

LevofloxacinRifaximinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Internal Medicine, Erciyes University, Kayseri, Türkiye.
  • Faculty of Medicine, Internal Medicine, Hematology Department, Erciyes University, Kayseri, Türkiye. Electronic address: akyolg@erciyes.edu.tr.
  • Faculty of Medicine, Internal Medicine, Hematology Department, Erciyes University, Kayseri, Türkiye.
  • Hematology Department, Medipol University, İstanbul, Türkiye.

Zitieren

APA

Patat, Y., Akyol, G., Keklik, M., Ünal, A., & Kaynar, L. (2026). Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation. Transplantation Proceedings, 58(4), 816-821. https://doi.org/10.1016/j.transproceed.2026.03.015

Vancouver

Patat Y, Akyol G, Keklik M, Ünal A, Kaynar L. Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation. Transplantation Proceedings. 2026;58(4):816-821. doi:10.1016/j.transproceed.2026.03.015

BibTeX
@article{Patat2026,
  author = {Patat, Yakub and Akyol, Gülşah and Keklik, Muzaffer and Ünal, Ali and Kaynar, Leylagül},
  title = {Rifaximin Versus Levofloxacin: A Comparative Analysis of Prophylactic Efficacy in Allogeneic Stem Cell Transplantation},
  journal = {Transplantation Proceedings},
  year = {2026},
  volume = {58},
  number = {4},
  pages = {816--821},
  doi = {10.1016/j.transproceed.2026.03.015}
}
Kostenlos starten →